How might Evernorth expand its Accredo specialty pharmacy services to provide more personalized support for patients with rare diseases?

Introduction

To expand Evernorth's Accredo specialty pharmacy services for more personalized support for patients with rare diseases, we need to focus on enhancing the patient experience, leveraging technology, and addressing unique challenges faced by this specific patient population. I'll approach this by analyzing our current offerings, identifying key pain points, and proposing innovative solutions that align with Evernorth's broader objectives.

Step 1

Clarifying Questions

• Looking at Accredo's current services, I'm curious about the specific rare diseases we're targeting. Could you provide more information on the top 3-5 rare diseases our patients are dealing with?

Why it matters: Different rare diseases have unique treatment protocols and patient needs, which will significantly impact our personalization strategy. Expected answer: Hemophilia, Gaucher disease, and Fabry disease are our top focus areas. Impact on approach: We'd tailor our solutions to address the specific challenges of these conditions.

• Considering the complexity of rare disease management, I'm wondering about our current patient engagement model. How frequently do our patients interact with Accredo services, and through what channels?

Why it matters: Understanding the current touchpoints will help us identify opportunities for more personalized interventions. Expected answer: Patients typically interact monthly via phone and occasionally through a web portal. Impact on approach: We might focus on increasing digital touchpoints and proactive outreach.

• Given the specialized nature of rare disease treatments, I'm interested in our current data collection and analysis capabilities. What types of patient data are we currently collecting, and how are we using it to personalize care?

Why it matters: Effective personalization relies heavily on comprehensive data and advanced analytics. Expected answer: We collect basic medical history and medication adherence data, with limited use of predictive analytics. Impact on approach: We might prioritize expanding our data collection and implementing more sophisticated analytics tools.

• Considering the potential for digital health solutions in rare disease management, I'm curious about our current technology stack. What digital tools or platforms are we currently using to support patients with rare diseases?

Why it matters: Understanding our technological capabilities will inform the feasibility of potential solutions. Expected answer: We have a basic patient portal and mobile app with limited functionality. Impact on approach: We might focus on enhancing our digital offerings and integrating more advanced features like telemedicine or IoT device integration.